Kenvue Inc. $KVUE Stock Holdings Increased by State of Wyoming

State of Wyoming raised its holdings in shares of Kenvue Inc. (NYSE:KVUE) by 233.5% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 97,992 shares of the company’s stock after purchasing an additional 68,609 shares during the quarter. State of Wyoming’s holdings in Kenvue were worth $1,690,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of KVUE. Norges Bank bought a new stake in shares of Kenvue during the 4th quarter worth $756,862,000. Van ECK Associates Corp boosted its position in shares of Kenvue by 101.3% in the 3rd quarter. Van ECK Associates Corp now owns 18,361,581 shares of the company’s stock valued at $298,008,000 after purchasing an additional 9,240,434 shares during the period. American Century Companies Inc. increased its stake in Kenvue by 22.4% in the 3rd quarter. American Century Companies Inc. now owns 37,046,660 shares of the company’s stock worth $601,267,000 after purchasing an additional 6,781,640 shares in the last quarter. Bessemer Group Inc. raised its holdings in Kenvue by 156.2% during the 4th quarter. Bessemer Group Inc. now owns 8,491,343 shares of the company’s stock worth $146,475,000 after buying an additional 5,177,404 shares during the period. Finally, Mondrian Investment Partners LTD purchased a new stake in Kenvue during the third quarter valued at about $79,269,000. Institutional investors own 97.64% of the company’s stock.

Insider Activity at Kenvue

In other news, General Counsel Matthew Orlando sold 38,491 shares of the firm’s stock in a transaction on Friday, May 8th. The stock was sold at an average price of $17.66, for a total value of $679,751.06. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 1.59% of the company’s stock.

Kenvue Trading Down 2.7%

Shares of KVUE opened at $16.86 on Thursday. The company has a current ratio of 0.98, a quick ratio of 0.70 and a debt-to-equity ratio of 0.67. The stock has a market cap of $32.37 billion, a PE ratio of 19.84, a PEG ratio of 1.31 and a beta of 0.54. Kenvue Inc. has a 1 year low of $14.02 and a 1 year high of $22.87. The stock has a 50 day simple moving average of $17.38 and a 200-day simple moving average of $17.47.

Kenvue (NYSE:KVUE) last issued its quarterly earnings data on Thursday, May 7th. The company reported $0.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.27 by $0.05. The company had revenue of $3.91 billion during the quarter, compared to analysts’ expectations of $3.84 billion. Kenvue had a return on equity of 20.81% and a net margin of 10.61%.The business’s revenue was up 4.5% on a year-over-year basis. During the same period last year, the business earned $0.24 earnings per share. On average, sell-side analysts predict that Kenvue Inc. will post 1.16 EPS for the current fiscal year.

Kenvue Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 27th. Investors of record on Wednesday, May 13th were issued a dividend of $0.2075 per share. This represents a $0.83 dividend on an annualized basis and a yield of 4.9%. The ex-dividend date of this dividend was Wednesday, May 13th. Kenvue’s dividend payout ratio (DPR) is currently 97.65%.

Analysts Set New Price Targets

Several research analysts have recently weighed in on KVUE shares. Canaccord Genuity Group lifted their target price on shares of Kenvue from $17.00 to $18.00 and gave the stock a “hold” rating in a research report on Wednesday, February 18th. UBS Group reduced their price objective on shares of Kenvue from $19.00 to $18.00 and set a “neutral” rating for the company in a research note on Tuesday, April 7th. Zacks Research raised Kenvue from a “hold” rating to a “strong-buy” rating in a research report on Friday, May 8th. Weiss Ratings downgraded shares of Kenvue from a “hold (c)” rating to a “hold (c-)” rating in a research note on Friday, May 29th. Finally, Citigroup cut their price objective on shares of Kenvue from $20.00 to $19.00 and set a “neutral” rating for the company in a research report on Wednesday, April 15th. One investment analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and twelve have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $19.33.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.